Introduction
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Primary neonatal foreskin keratinocytes are the most commonly employed human an in vitro culture of keratinocytes from biopsy specimens. These issues can include, but are not 48 limited to, microbial and fibroblast contamination 1 , low cellular viability and/or yield, and limited 3 culture lifespan 2 . Previous studies demonstrated low colony forming efficiency 3 , limited potential to 50 passage cultures 4 , and low adherence of viable cells 5 . Even with established methods, cultures from 51 upper respiratory tract HPV lesions could be established from less than one-third of biopsy specimens 52 and possessed a limited lifespan in vitro 2 . Currently, there is no literature on generating three-53 dimensional organotypic raft cultures (organoids) from patient-derived, naturally-infected cervical 54 keratinocytes. Organoids have additional uses as they maintain many pathogen-host interactions 55 while bypassing the need for animal models. Indeed, organoids have been used to test antiviral drugs 56 against herpes viruses 6 and poxviruses 7 , as well as topical treatments for head and neck squamous 57 cell carcinoma 8 . It would seem feasible then to test new antiviral agents against HPV such as the ones 58 developed by us 9 in organoid models.
59
In this observational case series study, we developed a patient-based cell culture model using 60 freshly excised, cervical biopsies as a more accurate alternative to traditional cervical cancer-derived 61 cell lines such as SiHa and CaSki. Success was defined on how many samples could be propagated 62 at least once, and then grown long enough to precisely define their proliferation profile over time and 63 whether freeze backs could be made and resuscitated for additional experiments. Initial results based 64 on published methods [1] [2] [3] [4] [5] were clearly improved by altering cell culture conditions, and biopsy-7 effectively than insulin receptors 12 . Moreover, IGF-I is more potent than insulin at activating MAPK 133 in keratinocytes 13 to stimulate proliferation via mitogenic signalling. To avoid stress signalling via 134 the Rho pathway 14 , we also added the Rho kinase (ROCK) inhibitor Y-27632 (Fisher Scientific) to 135 the medium. We reasoned this would further inhibit the differentiation of epithelial cells potentially 136 resulting in increased keratinocyte proliferation 15, 16 . Inhibition of ROCK reduces expression of down-137 stream targets for p53, which is thought to be a major mechanism by which Y-27632 promotes 138 growth.
139
The immortalized mouse embryonic fibroblast cell line J2 3T3 17 and primary human foreskin 140 fibroblasts (ATCC, Cat. No. CRL-2097) were cultured in DMEM containing 10% heat-inactivated 141 FBS and 1X antibiotic/antimycotic (Fisher Scientific) . When passaging cultures, cell monolayers 142 were washed with DPBS before adding 2 mL of 0.05% trypsin containing 0.02% 143 ethylenediaminetetraacetic acid (trypsin-EDTA; Fisher Scientific) and incubated at 37°C for 5-10 144 minutes until cells were sufficiently detached, at which point 4 mL of culture medium was added to 145 inactivate the trypsin. Cultures were seeded at 10% confluence and maintained up to 80% confluence 146 before subsequent passaging. PDT was calculated by subtracting the difference between the log of 147 the later population size from the log of the initial population size. The difference between the two 148 values was divided by 0.301 (log of 2) to obtain the number of total PDs. PD time ( 
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Initially, the cervical rafts were grown with an in-house made medium as previously 164 described for skin 3D organotypic rafts 19, 20 . As this approach yielded less than expected epithelial 165 multi-layering in the current study, we switched to a recently launched 3D medium specifically 166 developed for growing rafts from gingival mucosal keratinocytes (CellnTec Advanced Cell Systems 167 AG). This and doubling the number of fibroblasts showed the desired improvement in the growth 168 process (multi-layered epithelium). Rafts were prepared in 3 to 6 technical replicates for each patient 169 culture.
170
On day 1, low passage (P<5) human fibroblasts were used in the preparation of dermal 171 equivalents. For 10 rafts, 0.8 x 10 6 fibroblasts were re-suspended in 0.8 mL FBS. Using a sterile 10 172 mL beaker with a magnetic stir bar, cooled in ice atop a magnetic stir plate, 3 mL of type I rat tail 9 solution was neutralized using 5 µL increments of 5 N NaOH, requiring ~ 10-15 µL in total. Once were then incubated for 20 minutes at 37°C to solidify. Afterwards, 500 µL of DMEM-FBS was 178 added on top of each DE and incubated overnight.
179
On day 2, for each raft, 0.25 x 10 6 patient keratinocytes were re-suspended in 50 µL of 180 EpiLife medium and seeded on top of the DE (to form the basal layer of the epidermis). After 2 hours, 181 500 µL of EpiLife with ROCK inhibitor was added to each raft and incubated overnight.
182
On day 3, the medium was removed, and rafts lifted to the air-liquid interface. A micro spoon 183 was used to transfer the rafts from the 48-well plate onto Millicell 30 mm, 0.4 µm inserts (Millipore) 184 placed in 6-well plates, where 1.1 mL of 3D medium was added around each insert, at one insert per 185 well. The 3D medium was replaced every 2 days, where residual medium that accumulated around 186 the rafts on top of well-insert membranes was removed. After 14 days, rafts were fixed overnight in 187 10% buffered formalin (Fisher Scientific). The rafts were subsequently washed once and stored in 188 70% denatured ethanol (Fisher Scientific) until processed further for histological assessment. We also 189 characterized their p16 and cervical (mucosal) cytokeratin (CK) status (CK14, 17 and 19) by 
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For phase 2, which included patient chart review, altered laboratory protocols and HPV 211 typing, an amendment was requested in June of 2017, after the study was renewed and the summary 212 of the initial results was provided to the REBs. This amendment was granted through both institutions 213 and the acquisition of samples for phase 2 began again in July of 2017.
215
From an original 60 cases (one biopsy per patient), 42 biopsies from women aged between 218 22 to 69 were finally evaluated for whether or not keratinocyte subcultures could be established, i.e. 219 could be passaged at least once: a positive yield based on this criterion was obtained in 10/42 cases 220 (~ 24%): 3/20 in phase 1 (15%) and 7/22 in phase 2 (32%). For phase 2, biopsies tended to be smaller 221 in size, average days in culture until passage 1 was half that of phase 1 and longevity decreased by 222 25% (Tables 1, 2). All but 1 case were HPV-positive, 6 cases were lesion-free and approximately half 223 digested well with collagenase (Table 2) were roughly a uniform 4 mm across. The remaining specimens (10/20) were in between these sizes 230 (typically 2-3 mm wide and 1-2 mm in height and depth). The type of biopsy forceps used for 231 excision depended on lesion size; hence, biopsy size varied according to lesion size and location, and 232 the ease of accessing it with the forceps. There were notable differences in the ability to establish 233 proliferative cultures from the various biopsy sizes ( Table 1 ). The ability to establish growing cultures 234 from biopsy specimens seemed to correlate with size as the 3 cases that could be passaged at least 235 once either derived from medium or large biopsies. However, this finding was not statistically 236 significant (Fisher's exact test for count data, P = 0.850). Differentiation was evident upon 237 microscopic examination, as cultures would exhibit noticeably reduced growth (i.e. modest changes 
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Cases follow in chronological order reflecting when biopsies were taken. Note that of 30 specimens 240 acquired, only 20 are included in this table as explained in Materials and Methods. Only 3/11 241 specimens that initially yielded colonies were proliferating. Samples were divided into 4 groups: 242 0=No colonies of keratinocytes on starting in a T12.5 flask; 1=Visible colonies of keratinocytes but 243 either no or too little growth to move to next size flask (i.e. from T12.5 to T25); 2=transfer to next 244 size flask possible (T12.5 to T25); 3=transfer to next size flask possible (T25 to T75). Flask scaling:
245
We typically split the T12.5 flask to the next size T25 flask once it was ~ 50% confluent because the 246 centre of the colonies was typically quite dense; the T25 flask was trypsinized at ~ 80% confluence 247 and all recovered cells were seeded on the subsequent T75 flask. in confluence over the course of one week). Cells would then cease to proliferate and markedly 251 increase in cross-sectional area for approximately one or two more weeks (Figure 1 ). Therefore, 252 lifespan was estimated retrospectively from the dates by which cells dramatically increased in size 13 and had previously shown decreased proliferation (usually ~ 50% should have differentiated for the 254 culture to be assessed as "differentiated"). Days in culture until passaged the first time was a mean of 255 32 days (range 28-38) and the average time until differentiation was 48 days (Table 1 ). An example 256 of how keratinocytes grow out of digested tissue is displayed in Figure 2 . 
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Case ID Category Days to passage 1 collagenase. This observation appeared to be correlated with establishing colonies and therefore, in 295 phase 2, it was noted whether each biopsy digested well or poorly as an additional parameter.
Days of life span
Size of biopsy
296
Observations and results for establishing cultures are listed in Table 2 . Days in culture until 16 passaged the first time was a mean of 16 days (range 9-21) and the average culture lifespan was 36 298 days.
299
We assessed the predictive value of 4 independent variables: biopsy size, digestion, lesion 300 grade, and HPV status. Most patients (82%) were found to be in their mid-twenties to mid-thirties, 
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Rafting did not succeed in these cases where only a couple of layers would form. In contrast, 3UI, 332 AV6, and Z5X could all be grown as rafts ( Figure 3 ) and showed homogeneously small cells (i.e. 
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It is now possible to purchase hysterectomy-derived cervical keratinocytes from at least 3 357 independent vendors. An inquiry, with one of them replying, revealed that they guarantee 3 passages 358 with a total of 10 PDs and a PDT typically between 40 to 70 hours (depending on medium 359 composition). In the Fan and colleagues' study 24 , where keratinocyte cultures were likewise obtained 360 from hysterectomies, 5-6 passages with 1 PDT per passage was reported. Taken together, this 361 suggests that our samples outperform both these accomplishments despite the fact that they originated 362 from biopsies: an average of 8 passages, each with 3 PDs, and a PDT of 27 hours, expecting to yield 363 several hundred million cells while also preparing cell stocks. Other studies did not report their data 364 in a similarly quantitative manner [1] [2] [3] [4] [5] , precluding any meaningful comparison with our results. The 365 current study seems to be stand-alone to systematically investigate the culturing of biopsy-derived, 20 cervical keratinocytes both as monolayers and organotypic rafts. We also report success and 367 shortcomings in a descriptive and quantitative, open-ended manner implying that there is still room 368 for improvement.
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The biggest variance between phase 1 and phase 2 was the proliferation efficiency, which is 370 likely an effect from our adopted medium condition with IGF-1 and ROCK inhibitor components.
371
While both components may have helped to increase proliferation of progenitor cells short term, they 372 may cause "proliferative exhaustion" after an initial enhancement due to an increase in mitosis. Long-373 term, however, exposure to IGF-1 has been shown to induce premature senescence, e.g. through 374 inhibition of SIRT1-mediated p53 deacetylation 25 , which may explain the somewhat shorter temporal 375 lifespan in phase 2 compared to phase 1. Boosting stem cells that potentially reside in the obtained 376 biopsies will therefore be considered as a next step to generally increase the yield of cultures. 
